Human recombinant insulin-like growth factor I. II. Binding characterization and radioreceptor assay development using BALB/c 3T3 mouse embryo fibroblasts

1988 ◽  
Vol 24 (11) ◽  
pp. 1107-1113 ◽  
Author(s):  
Kenneth P. Karey ◽  
Terry L. Riss ◽  
B. Daniel Burleigh ◽  
David Parker ◽  
David A. Sirbasku
1997 ◽  
Vol 17 (7) ◽  
pp. 3744-3754 ◽  
Author(s):  
B Valentinis ◽  
A Morrione ◽  
S J Taylor ◽  
R Baserga

R- cells, a line of mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I (IGF-I) receptor genes, are refractory to transformation by several viral and cellular oncogenes. Using colony formation in soft agar as a measure of full transformation, we report here that R- cells can be transformed by v-src, although they still cannot be transformed by the activated c-src527 (mutation at tyrosine 527 to phenylalanine), which readily transforms mouse embryo cells with a wild-type number of IGF-I receptors (W cells). Although v-src is a more potent inducer of tyrosine phosphorylation than c-src527, the extent of phosphorylation of either insulin receptor substrate 1 or Shc, two of the major substrates of the IGF-I receptor, does not seem sufficiently different to explain the qualitative difference in soft agar growth. v-src, however, is considerably more efficient than c-src527 in its ability to tyrosyl phosphorylate, in R- cells, the focal adhesion kinase, Stat1, and p130cas. These results indicate that v-src, but not c-src527, can bypass the requirement for a functional IGF-I receptor in the full transformation of mouse embryo fibroblasts and suggest that qualitative and quantitative differences between the two oncogenes can be used to identify some of the signals relevant to the mechanism(s) of transformation.


2006 ◽  
Vol 66 (8) ◽  
pp. 4233-4239 ◽  
Author(s):  
Susan L. Spence ◽  
Arthur L. Shaffer ◽  
Louis M. Staudt ◽  
Sewit Amde ◽  
Sutana Manney ◽  
...  

1993 ◽  
Vol 296 (3) ◽  
pp. 765-769 ◽  
Author(s):  
E Roth ◽  
L Valentini ◽  
T Hölzenbein ◽  
S Winkler ◽  
T Sautner ◽  
...  

The effects of acute administration of human recombinant insulin-like growth factor-I (rhIGF-I) on amino acid (AA) flux between hindlimbs, liver and gut were investigated in anaesthetized post-operative dogs. rhIGF-I produced about a 10-fold increase in plasma IGF-I concentrations above baseline values (P < 0.001), increased the plasma levels of glucagon and adrenaline (P < 0.05), and evoked a fall in plasma glucose (-55 +/- 8%; (P < 0.001) and plasma total AA levels (-23 +/- 8%; P < 0.05). AA flux in post-absorptive dogs under NaCl infusions was characterized by an efflux of AA from the hindlimbs (as a result of the protein-catabolic situation), an equal AA balance across the gut and an AA uptake by the liver. The administration of rhIGF-I increased hepatic AA uptake in the NaCl group from 3.51 +/- 0.8 to 7.5 +/- 0.4 mumol/min per kg (P < 0.01) and in the AA-infused group from 16.8 +/- 0.6 to 22.4 +/- 1.5 mumol/min per kg (P < 0.05), but did not influence the AA balance across hindlimbs and gut. Glucose infusions normalized the plasma concentrations of counter-regulatory hormones without influencing the inter-organ AA balances. We conclude that hypoaminoacidaemia caused by rhIGF-I infusions is the result of a stimulated AA uptake by the liver, but is unrelated to alterations of AA exchange across the hindlimbs.


1992 ◽  
Vol 37 (6) ◽  
pp. 542-551 ◽  
Author(s):  
John P. Miell ◽  
Alastair M. Taylor ◽  
Jennifer Jones ◽  
Charles R. Buchanan ◽  
John Rennie ◽  
...  

1997 ◽  
Vol 25 (8) ◽  
pp. 1352-1361 ◽  
Author(s):  
Gary D. Yarwood ◽  
Richard J. M. Ross ◽  
Sami Medbak ◽  
John Coakley ◽  
Charles J. Hinds

Sign in / Sign up

Export Citation Format

Share Document